The real story about CFS: a devastating illness that needs a better name

Garnet news article by Maureen Hanson, 19 October 2016: The real story about Chronic Fatigue Syndrome: a devastating illness that needs a better name

Chronic Fatigue Syndrome is an illness that many may have heard of, but few, in reality, know much about.

The effect of the name

The misconception of the seriousness of the disease is in part caused by the use of the name Chronic Fatigue Syndrome (CFS), coined in 1988 by a committee convened at the Centers for Disease Control. Prior to that recommendation, the disease was known by the more intimidating name Myalgic Encephalomyelitis (ME), which is favored by many patients and still used in many countries overseas. Chronic Fatigue Syndrome trivializes the nature of the disease and its impact on the lives of the people who suffer with it.

For individuals severely ill with ME/CFS, merely arising from bed to take a shower, or leaving the house to go to a medical appointment, can cause them to be bedridden several days afterward. Some people cannot manage to get out of bed at all.

The name influences not only the public’s conception of the disease but also that of medical professionals. As a point, in fact, College students and medical trainees who were given identical scenarios were more likely to consider patients described as having myalgic encephalopathy as having a biomedical illness, while patients labeled as having chronic fatigue syndrome were more likely to be thought to be psychiatric cases.

Four times as many women as men fall ill with ME/CFS. Many doctors dismiss women’s descriptions of ME/CFS symptoms as depression or emotional disturbance.

A new name

Recognizing the effect of naming the disease Chronic Fatigue Syndrome on patients and doctors an Institute of Medicine study recommended changing the name Systemic Exertion Intolerance Disease.  The name refers to a primary symptom of the illness, post-exertional malaise, which is an increase in symptoms when a victim attempts to do some previously tolerable exertion.  Most patients reach a steady-state level of exertion that they know from experience that they can bear, and exceed it only when absolutely necessary, as they know the consequence will be a subsequent increase in pain, malaise, fatigue, and cognitive difficulties that will last days or weeks.

The images of the disease

But even a name change, which to be truthful, has not really caught on, won’t solve the problem when the imagery associated with the disease continues to be benign and misleading. As we all know, images are powerful and associating the wrong ones with the disease only helps to spread misinformation.

An exception is currently on an display in Times Square in New York: a video broadcast by the SolveME/CFS Initiative, a patient advocacy organization, which shows photos of genuine, severely ill Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) patients.

derails-destroys-steals

The SolveMe/CFS Initiative

New Research Encounters Same Bias

These images are quite a contrast to many that accompanied the multitude of news reports about the recent scientific publication about abnormalities in the gut microbiome in ME/CFS.  In June, a team of researchers which I was a part of, reported our discovery that the populations of bacteria in the gut of individuals with the disease are abnormal compared to healthy individuals.  Increased escape of bacteria from the gut into the bloodstream appears to trigger inflammation in some ME/CFS victims.

This new information was the topic of more than 70 articles in the lay and medical press.

All the attention on our work had a chance to educate people about the actual life-robbing nature of the disease.

But the photos chosen to illustrate many of these articles spread persistent misconceptions about the disease.

There were several categories of photographs used to illustrate the news reports about our gut microbiome findings: microscopic images of bacteria, anatomical drawings with intestines highlighted, and photographs of people thought to be experiencing ME/CFS.

But many of the photos of patients with the disease were completely inappropriate, resulting from the misunderstanding that fatigue is not only the primary, but also the only symptom of the disease.

Indeed, one article was entitled: “Gut bacteria can make you tired.”

Fatigue is a common effect of other diseases as well, including multiple sclerosis and cancer.  But no one would illustrate an article about either of those diseases with someone sleeping at her computer, a woman snoozing with coffee cup in hand, or a woman who has evidently just come home from work, gazing wearily at children’s toys scattered around the floor. Another photo shows a woman lying on a couch with light from a nearby window streaming onto her face.  ME/CFS victims are unlikely to be in such a pose, given that most are quite sensitive to light and some must confine themselves to dark bedrooms.

When the underlying cause of the disorder is finally understood, undoubtedly a new and more accurate name will arise.  In the meantime, it’s important for editors at news outlets and health news bloggers to not only cover the disease accurately but to select images that represent the true nature of the disease that is described by the Institute of Medicine as  “a serious, chronic, complex, and multisystem disease that frequently and dramatically limits the activities of affected patients.”

Maureen Hanson is Professor of Molecular Biology and Genetics at Cornell University and conducts NIH-supported research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. She is a Public Voices Fellow of The OpEd Project.

Posted in News | Tagged , , , , | Comments Off on The real story about CFS: a devastating illness that needs a better name

Elevated energy production by non-mitochondrial sources in CFS sub-group

Research abstract:

Chronic Fatigue Syndrome (CFS) is a debilitating disease characterized by physical and mental exhaustion. The underlying pathogenesis is unknown, but impairments in certain mitochondrial functions have been found in some CFS patients. To thoroughly reveal mitochondrial deficiencies in CFS patients, here we examine the key aspects of mitochondrial function in blood cells from a paired CFS patient-control series.

Surprisingly, we discover that in patients the ATP levels are higher and mitochondrial cristae are more condensed compared to their paired controls, while the mitochondrial crista length, mitochondrial size, shape, density, membrane potential, and enzymatic activities of the complexes in the electron transport chain remain intact.

We further show that the increased ATP largely comes from non-mitochondrial sources. Our results indicate that the fatigue symptom in this cohort of patients is unlikely caused by lack of ATP and severe mitochondrial malfunction. On the contrary, it might be linked to a pathological mechanism by which more ATP is produced by non-mitochondrial sources.

Discussion:

CFS afflicts millions of people, but its underlying cause remains elusive. In this study, by examining mitochondrial phenotypes in depth in a patient-control series, we have revealed that there is no major mitochondrial defect in CFS patients. Despite finding that mitochondrial cristae are more condensed, the mitochondrial morphology, the ETC, and the ΔΨ remain intact in CFS patients compared to their paired controls. Intriguingly, we have shown that ATP production is stimulated in CFS patients, and the elevated ATP content mainly comes from non-mitochondrial sources.

Our results present an unorthodox view on CFS pathology: the fatigue is not caused by lack of ATP, and instead might be caused by a pathological process linked to non-mitochondrial ATP production such as glycolysis.

Mitochondrial crista architecture is exquisitely and dynamically maintained to support the changing mitochondrial aerobic respiratory rate 26-30. The membrane area and number of cristae are expanded upon energy need elevation to promote respiratory activities 31,32. The fact that the crista number is increased in CFS patients suggests that their energy demands might be unusually high, which triggers condensation of mitochondrial crista membranes.

The contrasting results of the ATP levels in different cohort of patients 11,13-15 (this study) indicate that CFS is a complex disease and the current diagnoses may include people with varying molecular dysfunctions. A better categorization of patients with differing cellular defects will allow researchers to better understand the underlying causes and improve treatment efficacy. Future studies are warranted to unravel why and how non-mitochondrial ATP production is activated in some patients, which will yield insights into novel strategies to address the pathological causes.

Elevated Energy Production in Chronic Fatigue Syndrome Patients, by N Lawson, CH Hsieh, D March, X Wang in J Nat Sci. 2016;2(10). pii: e221

 

Posted in News | Tagged , , , , , , , | Comments Off on Elevated energy production by non-mitochondrial sources in CFS sub-group

Case report of differences between twins where only one has ME

Case report abstract:

BACKGROUND: Patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) present with profound fatigue, flu-like symptoms, pain, cognitive impairment, orthostatic intolerance, and post-exertional malaise (PEM), and exacerbation of some or all of the baseline symptoms.

CASE REPORT: We report on a pair of 34-year-old monozygotic twins discordant for ME/CFS, with WELL, the non-affected twin, and ILL, the affected twin. Both twins performed a two-day cardiopulmonary exercise test (CPET), pre- and post-exercise blood samples were drawn, and both provided stool samples for biochemical and molecular analysis.

At peak exertion for both CPETs, ILL presented lower VO2peak and peak workload compared to WELL. WELL demonstrated normal reproducibility of VO2@ventilatory/anaerobic threshold (VAT) during  CPET2, whereas ILL experienced an abnormal reduction of 13% in VAT during  CPET2.

A normal rise in lactate dehydrogenase (LDH), creatine kinase (CK), adrenocorticotropic hormone (ACTH), cortisol, creatinine, and ferritin content was observed following exercise for both WELL and ILL at each CPET. ILL showed higher increases of resistin, soluble CD40 ligand (sCD40L), and soluble Fas ligand (sFasL) after exercise compared to WELL.

The gut bacterial microbiome and virome were examined and revealed a lower microbial diversity in ILL compared to WELL, with fewer beneficial bacteria such as Faecalibacterium and Bifidobacterium, and an expansion of bacteriophages belonging to the tailed dsDNA Caudovirales order.

CONCLUSIONS: Results suggest dysfunctional immune activation in ILL following exercise and that prokaryotic viruses may contribute to mucosal inflammation and bacterial dysbiosis. Therefore, a two-day CPET and molecular analysis of blood and microbiomes could provide valuable information about ME/CFS, particularly if applied to a larger cohort of monozygotic twins.

A Pair of Identical Twins Discordant for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Differ in Physiological Parameters and Gut Microbiome Composition by Ludovic Giloteaux, Maureen R. Hanson, Betsy A. Keller in Am J Case Rep 2016; 17:720-729

 

Posted in News | Tagged , , , , | Comments Off on Case report of differences between twins where only one has ME

Dr Mark Porter on the challenge of IBS, pregabalin & BAD

The Times article, by Dr Mark Porter, 18 October 2016: Not all of the six million Brits who think they have IBS need to hang on for the new wonder drug

Part of the challenge is that IBS is unlikely to be one disorder

At least six million people in the UK are regularly troubled by symptoms of irritable bowel syndrome (IBS), so it should come as no surprise that an effective treatment has long been the holy grail of pharmaceutical companies working in the gastrointestinal arena. They are yet to make a significant breakthrough.

The latest advance, however, comes from the US, where researchers at the prestigious Mayo Clinic have announced that pregabalin — a drug used to treat neuralgia and anxiety — eases the discomfort associated with IBS. Yet it is early days and pregabalin may go the way of other breakthroughs in this area, which have all failed to live up to early promise.

Part of the challenge is that IBS is unlikely to be one disorder. It is simply a diagnosis of exclusion — an umbrella term to explain groups of symptoms that can’t be attributed to anything else. At least that is what it is supposed to be.

In recent years it has become clear that many people with problems previously attributed to IBS may have another condition. If you have the type of IBS associated with diarrhoea/loose stools — about half of people do — your symptoms may be more manageable than you think; as many as half a million sufferers are thought to have idiopathic bile acid diarrhoea (BAD) caused by an excess of bile in the lower bowel. We all produce about eight litres of digestive juices each day, including up to a litre of bile that helps us to absorb fat. Nearly all of these juices are reabsorbed before they reach the lower part of the gut, but this process goes awry in BAD.

The volume of digestive juices is the reason why gastroenteritis can quickly lead to dehydration. If the intestinal transit time is dramatically increased by infection-induced inflammation, there is not enough time to absorb the digestive juices and you can pass litres a day, even if you have had only a cup of tea and nibbled on a biscuit. With BAD there is no infective virus or bacteria, but the unabsorbed bile has an irritant effect on the lower bowel, increasing transit time in a similar fashion.

There are some good medical reasons why the bile reabsorption mechanism is hampered in some people — ranging from inflammatory bowel disease to gall bladder removal — but for those with idiopathic BAD there appears to be a genetic glitch in the transport system responsible for collecting and recycling bile salts. The result is that too much bile reaches the colon.

As well as the characteristic bloating and discomfort you get with IBS, tell-tale signs of BAD include unusual-coloured stools (shades of green or yellow) that are difficult to flush away, and needing to go to the loo during the night. Symptoms tend to be worse after fatty meals because these induce more bile secretion.

Specialist gastroenterology clinics have access to a specific test to confirm BAD, but it is expensive and not routinely available. A more pragmatic approach is to consider a trial of therapy with a granular drink (cholestyramine) that mops up bile. If this works it suggests that your IBS is in fact BAD.

The trick is to reduce the cholestyramine (mixed with water into a rather unpleasant wallpaper paste-like drink) to the bare minimum dose that controls the symptoms — often one or two sachets a day are enough. Other tips include switching to a low-fat diet and making breakfast and lunch your main meals of the day and only snacking in the evening.

So, while we await a “cure” for IBS, our best hope remains research into other possible underlying causes. And I very much doubt BAD will be the only “new” discovery in this field as we increase our understanding of the gut and the billions of friendly bacteria that live in it.

Posted in News | Tagged , , , , , , , , | Comments Off on Dr Mark Porter on the challenge of IBS, pregabalin & BAD

A qualitative study of depression in young people with CFS/ME

Research abstract:

Background: Paediatric chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) has a prevalence of 0.4–2.4% and is defined as ‘generalised disabling fatigue persisting after routine tests and investigations have failed to identify an obvious underlying cause’.

One-third of young people with CFS/ME have probable depression. Little is known about why depression develops, the relationship between depression and CFS/ME, or what treatment might be helpful.

Methods: We conducted nine semi-structured interviews with young people with CFS/ME (aged 13–17 years, 8/9 female) and probable depression, covering perceived causes of depression, the relationship between CFS/ME and depression, and treatment strategies.

Results: Most thought CFS/ME caused depression. Many discussed a cyclical relationship: low mood made CFS/ME worse. A sense of loss was common. CFS/ME restricted activities participants valued and changed systemic structures, causing depression. There was no single helpful treatment approach. Individualised approaches using combinations of cognitive behavioural therapy (CBT), medication, activity management and other strategies were described.

Conclusion: This study suggests that depression may be secondary to CFS/ME in young people because of the impact of CFS/ME on quality of life. Clinicians treating young people with CFS/ME need to consider strategies to prevent development of depression, and research is needed into approaches that are effective in treating CFS/ME with co-morbid depression

‘‘It’s personal to me’: A qualitative study of depression in young people with CFS/ME by Anna K Taylor, Maria Loades, Amberly LC Brigden, Simon M Collin and Esther Crawley in
Clin Child Psychol Psychiatry October 14, 2016  [Published online before print]

Posted in News | Tagged , , , , , , , , , , , , , | Comments Off on A qualitative study of depression in young people with CFS/ME

My final year at Oxford, when I felt punished for having ME

Guardian article by Nathalie Wright & Alice Woolley, 18 October 2016: My final year at Oxford, when I felt punished for having ME

For centuries Oxford has ‘rusticated’ students – expelled them to their family home in the country – and those who are ill receive the same treatment

Nathalie Wright had go through a ‘rustication’ process and sit exams to re-enter Oxford after she became ill in her final year.

nathalie-wrightPhotograph: Christopher Thomond for the Guardian

I had made it to the final year of my English degree at Oxford University, but I almost didn’t make it any further. I’d applied knowing the workload would be heavy but was still unprepared for the intensity of the course, which would often require two essays a week. For a single essay, we could be expected to read three novels as well as vast amounts of other reading. My peers and I would think nothing of doing a couple of all-nighters a week to stay on top of it. The next morning at breakfast, we would exchange tales of our martyrdom – someone had stayed up for three days straight reading Crime and Punishment, another had moved into the library, toothbrush and all.

This life shuddered to a halt when I suddenly became ill in the first term of my final year. I had glandular fever which, unbeknown to me then, had triggered ME – a chronic, extremely debilitating disease. As there was no way I could continue with my coursework, with the support of my GP I applied for a week’s extension. It was denied by the university.

So at a time when I should have been, under doctor’s orders, resting, I dragged myself to the library. When I collapsed on the front quad one day, I knew I had to go home. There, as I became sicker, it was clear to me I wouldn’t be able to go back to Oxford any time soon and would need a year out.

Becoming suddenly ill was hard enough but my distress was increased by the university’s reaction. A senior member of college staff tried twice on the phone to persuade me to go back the next term, as if I could simply make up my mind I was better and all would be well. It felt they did not believe I was ill; as if they thought I had something to gain from taking a year out, rather than losing a year of my life, in pain.

Although I had seen several doctors at home in Yorkshire, one of whom had sent a medical note to my college, Wadham, to say I was too ill to continue, the college said this wasn’t enough. Only the college doctor in Oxford could grant me a year off. This was standard college practice.

After weeks of distressing negotiations, I was allowed to suspend my studies for a year – with conditions. I was not allowed anywhere on college grounds (where all my friends lived) for the year. Worse, in order to rejoin my course after a year, I would have to sit six hours of exams and achieve a 2:1 standard. These exams were only for sick students.

ME is an illness where any kind of exertion – physical or mental – exacerbates symptoms. Doing extra exams on top of the huge quantity of revision I was expected to do would make me more ill, I knew. I put in a request to return without sitting exams but tutors said the papers were essential to prove that I could pass my finals. One said I needed to “toughen up”.

Eventually I bargained the college down to one three-hour exam. I spent two hours of it not knowing what to write but, somehow, I made it through.

Oxford is an old, creakingly traditional institution. Its website boasts that it is the oldest university in the English-speaking world, and some of the language still in everyday use is archaic. Oxford’s word for a year out of a degree is “rustication”. It’s from Latin (of course): “rus” means countryside, and the word was first used when students were expelled by being sent to their family home in the country. Officially, the word “suspension” is used now, but tutors and students alike still call it “rustication”. And it is more than just a word. This centuries-old attitude links being ill with being punished and seems to see those who need time off for health reasons as problem students to be banished and who have to prove themselves worthy before they are allowed back.

These re-entry exams are not official Oxford University policy but are usual practice in many colleges. In some cases, students have been required to sit the equivalent of all their finals, and get a 2:1 in them, to rejoin their course.

Last year, one student, Sophie Spector, at Balliol College, claimed she felt forced to leave Oxford altogether because of these kinds of exams, a case human rights lawyer Chris Fry described as “one of the more extreme examples of discrimination I have seen”.

In contrast with many universities, the vast majority of marks at Oxford are awarded based on exams sat at the end. Finals can be upwards of 30 hours of exams and are a test of mental and physical stamina as much as academic skills and knowledge. The arguments against changing the system are always the same – to protect the integrity of the course; the “unique” Oxford experience. But intellectual rigour has been confused with physical or mental fitness.

I spoke to several others who had been through “rustication”. One, who graduated in 2015, had been suffering mental health problems that led to her self-harming. Letters from her college, seen by the Guardian, refer to her “behaviour” at the time as “serious misconduct”. One referred to university regulations and told her that she was being suspended on disciplinary as well as medical grounds. She was not permitted to use college facilities, including “common rooms, the computing room, the dining hall, the lodge, the library and the college’s accommodation”.

She says: “At no point did I feel the main consideration was for my wellbeing. Rather than focus on sorting out my problems, I spent the year trying to recover from the trauma of having rusticated. My doctor told me a senior member of my college had described me as a ‘freak’.”

A recent history graduate summed up her feelings after asking for a year off as “humiliated”. She was told in a letter that she was not allowed to go into her college without written permission during her suspension “to ensure that students on course are not disrupted”. She was expected to sit two exam papers and achieve a mark of 60% before she could return. “Basically the whole process felt punitive, like I was being subjected to it because I had misbehaved.”

One college, Magdalen, was criticised for forbidding “rusticated” students from attending a college ball.

Many students are, thankfully, treated much better, but individual colleges are free to make many of their own rules, and students’ experience can be largely determined by senior staff. If tutors have an appropriate understanding of illness and disability, students are well supported. But change in Oxford is slow. Even the university’s own disability service, which I found helpful and supportive, cannot overrule the decisions of colleges in many cases.

Oxford students have been campaigning for improved care of sick and suspended students for years. Recently there have been minor reforms – “suspended” students can now borrow from university libraries in their year out and retain access to their email. But this does not go nearly far enough.

I put a comprehensive set of questions to the university covering the points made in this article. This was the response: “Suspension of study is a rare but helpful measure used by all universities to support students. Most suspensions are either at the student’s request or with their full agreement. We know it helps the overwhelming majority of students, who return to complete their courses successfully.

“Suspension is not something to be undertaken lightly, so colleges always make sure students explore every possible source of support before suspending. There is no question of students not being believed or supported when they experience difficulties. It is important that students only return when they are fully prepared to do so. In some cases, the assessment of fitness to return includes the setting of college exams.

“The colleges are working in consultation with Oxford University student union on a common approach and discussing both access to college facilities during suspension and academic conditions for return to study.”

In the end, I graduated in 2015 with a first, very much in spite of the extra obstacles I had experienced. Although my health has improved with time and rest, I am still debilitated. I believe that if Oxford had handled my illness more sensitively, it would have aided my recovery.

What do other universities do?
How unusual is Nathalie Wright’s experience? Education Guardian contacted 30 universities to find out about their procedures when a student needs time off for medical reasons – an “interruption” or an “abeyance”, as it’s usually called. The word “rustication” seems confined to Oxford, Cambridge and Durham – and in most institutions a “suspension” is more likely to be the result of some sort of misdemeanour.

We asked whether students were required to see an official “university doctor” or specialist, in addition to their own GP, for proof that they were ill. The answer, from those that replied, was “no” – all said a family doctor’s note was good enough.

Most said students who took time off were welcome to use campus facilities or visit friends and attend social functions, with a few restrictions. When attendance was not feasible, “virtual” access to libraries and virtual learning environments was often arranged.

ME affects four times as many women as men. Is that why we’re still disbelieved?
Nathalie Wright

All the universities that replied, with the exception of Cambridge, said they never set exams to check whether students had the required academic ability to return. The Cambridge spokesman said exams were sometimes set, but this was rare. “It’s a welfare issue because we’d want the student to be well cared for. We’d want both student and college to be reassured they were ready to come back and finish their degree.”

But is it right to equate performance in an academic exam with mental or physical health and fitness to return to studying?

“Doing exams to prove you are fit is something I have never heard of and may be of little, if any, practical use,” says Ruth Caleb, head of counselling at Brunel University and coordinator of the Mental Wellbeing in Higher Education working group. “Many mental and physical conditions, such as depression, anxiety, ME, Crohn’s disease or irritable bowel syndrome, are fluctuating so a student might be fit at one point, then unfit, or less fit, at others.”

There is little if any guidance for universities on how best to look after students who need to take a break from their studies. However, most institutions, motivated by the wish to see students complete their course, offer extra support on their return.

Alice Woolley

Posted in News | Tagged , , , , | Comments Off on My final year at Oxford, when I felt punished for having ME

Prof Hooper challenges value of CBT for ME

Article by Prof Malcolm Hooper, 15 October 2016: A response to Professor Fred Friedberg’s editorial about CBT

hooperProfessor Fred Friedberg asks why cognitive behavioural therapy (CBT) is so vilified in the chronic fatigue syndrome community.

He opens his Editorial by stating:

“Cognitive behaviour therapy (CBT) is a well-established psychosocial intervention for psychiatric disorders, pain management and stress related to medical  conditions”

(Editorial: Cognitive-behavior therapy: why is it so vilified in the chronic fatigue  syndrome community? Fatigue, Biomedicine, Health & Behavior 2016:vol 4: no:3:127-131) but  ME/CFS is not, and never has been, a psychiatric disorder and CBT has no more role in its  management than in the management of multiple sclerosis, MND, Parkinson’s Disease, malignancies  or other autoimmune disorders such as lupus or RA.
CBT is not mandated as the primary management approach in those other disorders, so why in  ME/CFS?

Patients with ME/CFS do not summarily reject any intervention that would help them: what they reject is a psychosocial intervention that is used with the intention of changing their correct  perception that they are very sick with an organic disease, not with a behavioural disorder that is curable by “cognitive re-structuring” if they would only co-operate.

Friedberg appears to assume that, where there is stress related to a medical disorder, CBT supports patients to help them cope better with their disease.

However, a key consideration which he fails to mention is the significant difference between supportive CBT and directive CBT.

In relation to ME/CFS, in the UK PACE trial CBT was not supportive but directive: Professor Sir Simon Wessely, currently President of the Royal College of Psychiatrists, has publicly stated: “CBT is directive – it is not enough to be kind or supportive” (New Statesman, 1st May 2008).

No amount of directive “cognitive re-structuring” can result in “recovery” from such a multi-system inflammatory disease process as has been demonstrated in ME/CFS.
The Centres for Disease Control (CDC) has archived its toolkit that recommended CBT and GET as interventions for ME/CFS (http://www.cdc.gov/cfs/toolkit/archived.html) and the National Institutes for Health (NIH) has produced a report which acknowledges the harm done to patients (http://annals.org/article.aspx?articleid=2322804); their conclusions were based on comprehensive reviews of over 9000 peer-reviewed research papers and testimony from expert researchers and clinicians.

Does this not provide the answer to Friedberg’s question as to why CBT is so vilified in the ME/CFS  community?

Diverting scarce resources from biomedical research by funding psychosocial interventions that have been conclusively proven to be ineffective can only harm patients further.

Money must now urgently be made available by institutions such as the MRC for research that is  relevant to the disorder; for example, Professor Faisal Khan (recently appointed to the Chair of Cardiovascular Sciences, Division of Molecular and Clinical Medicine at the University of Dundee) is working on NRF2 (nuclear receptor factor 2) in ME/CFS patients and his work ties in with the study by Japanese researchers who looked at index markers in ME/CFS patients with dysfunction of TCA (the tricarboxylic acid cycle, also known as the Krebs cycle, which is the biochemical pathway used to generate energy) and urea cycles (http://www.nature.com/articles/srep34990 ).

Behavioural researchers who for over 30 years have shown disregard for the scientific process should have no influence on future research.

Patients with ME/CFS do not need “behavioural” guidance from a profession which has visited such harm upon them.

To spell it out: directive CBT does not work for patients with ME/CFS and it is time that those psychologists and psychiatrists who insist that it does returned to reality.

Professor Malcolm Hooper
15th October 2016

Posted in News | Tagged , , , , , | 1 Comment

Depression-like symptoms in ME research – invitation to participate

Prof Leonard Jason writes on Facebook, 14 October 2016:

Our recent paper “Mortality in patients with ME and CFS” found patients are significantly at risk for earlier all-cause mortality with the top three causes of death being suicide, cardiovascular problems, and cancer. This is an alarming issue and we would like your help understanding what factors may be contributing to this earlier mortality.

In addition to developing cancer and cardiovascular problems, some individuals with ME and CFS exhibit symptoms similar to demoralization and depression due to the major symptoms of their primary physical illness and the associated limitations and stigma experienced.

We would like your help for our research study in understanding what external factors may be influencing the development and expression of demoralization and depression-like symptoms.

We would like to invite all individuals 18 or older with ME and CFS to complete our questionnaire (link below) assessing several factors including access to and quality of healthcare, illness severity, financial impact, and social interactions with both supportive and non-supportive people.

We hope the results of this study will help us better understand what you experience with your illness and the types of barriers to receiving quality care and support. This questionnaire will take approximately 90 minutes to complete. There is an opportunity to save pages and return later.

Online survey: An Assessment of Demoralization and Depression-like Symptoms Experienced by Individuals with ME and CFS

Posted in News | Tagged , , , , | Comments Off on Depression-like symptoms in ME research – invitation to participate

A teenager overcomes chronic fatigue

Wales online article, by Abbie Wightwick, 16 October 2016: A teenager’s determination overcame a debilitating condition that took her out of school 16 OCT 2016

Despite missing months of school, Sophie Irving is now eyeing up an Oxbridge bid
sophie-irvingSophie Irving, 16, from Cardiff, who overcame chronic fatigue syndrome

A teenager has described how she was struck down with Chronic Fatigue Syndrome at the age of 12.

Sophie Irving, 16, from Cardiff, said the syndrome started after she had a virus in year eight at Ysgol Glantaf.

“I had sinusitis and kept going to the doctor but didn’t have enough energy to do anything. I spent most of my time in the house. For three months I didn’t go to school or see friends.”

The schoolgirl had leg pains, headaches and exhaustion.

CFS does not show up on blood tests so her doctor sent her to the University Hospital of Wales in Cardiff where a specialist diagnosed it.

“CFS is a physical illness that is to do with chemicals in your brain,” said Sophie.

“There is no cure. You just have to push through. I was scared because I thought it was all in my head and started to doubt myself.”

Doctors advised Sophie to push herself and return to school for half days. By the start of year 10 she had returned full time.

But the pupil, who had been learning harp and piano as well as playing hockey and netball in and out of school, has cut back her activities and now just plays school netball.

READ MORE
The grim reality of being a 15-year-old girl and living with chronic fatigue syndrome

She got 14 GCSEs last summer, including 11A*s, two As and a B, is studying A levels and is considering going to medical school.

“My friends helped me a lot with copying up work when I missed lessons. I was discharged from the hospital after 14 months but it took me a year and a half to get back to normal.

“It was a real challenge to stay on top of my schoolwork.

“I was well enough to go back to school full time at the start of year 10, which was also the start of my GCSEs.

“I was worried about getting back into the swing of things. But after overcoming my condition, I was really motivated to work harder.”

Sophie says overcoming her illness made her more determined to catch up and do well at school. Sophie, who is studying A-level maths, history, chemistry, and physics, has been chosen for the Seren Network, a Welsh Government funded programme designed to stretch and challenge students beyond A-Level curriculum.

Selected students have access to reading lists and staff from leading UK universities including Oxford and Cambridge, while receiving subject support from teachers and information and advice about university applications.

Around 2,000 of Wales’s brightest A-level students have been invited to join the Seren Network.

Seren hubs for Merthyr/Rhonnda Cynon Taf, EAS (South East Wales Educational Achievement Service), Swansea, Wrexham/Flintshire, Pembrokeshire/Carmarthenshire, NPT/Bridgend/Powys, Cardiff, Anglesey/Gwynedd, and Conwy/Denbighshire have launched in the last year, with hubs in the Vale of Glamorgan and Ceredigion due to be launched soon.

Editorial note:  Chronic Fatigue Syndrome is a term that some people use to cover a range of conditions with a fatigue element, including ME. Some symptoms of ME, CFS, Fibromyalgia and Post viral fatigue syndrome overlap. It is important to be sure you have the correct diagnosis and pursue an appropriate management approach.

WAMES does not advise people with ME to ‘push through’.

A key characteristic of ME is the post exertional exacerbation of symptoms. In other words physical and mental activity can cause body systems to malfunction and symptoms to increase. Part of managing ME involves learning how much activity is too much at each stage of the condition.

There is only one known Consultant with an interest in ME in Wales – in Hywel Dda – so it can be difficult to get specialist confirmation of diagnosis and accurate management advice.

WAMES is working with Welsh Government officials and Health Board reps on the ME-CFS/FM All Wales Implementation Group to look for ways to improve healthcare for people with ME, CFS and Fibromyalgia. We would be interested in hearing your story of accessing healthcare in Wales for ME or CFS. Contact jan@wames.org.uk

Posted in News | Tagged , , , | Comments Off on A teenager overcomes chronic fatigue

Calcium mobilisation in natural killer cells & cell cytotoxicity in CFS/ME

Research abstract:

Transient receptor potential melastatin subfamily 3 (TRPM3) ion channels play a role in calcium (Ca2+ ) cell signalling. Reduced TRPM3 has been identified in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) patients. However, the significance of TRPM3 and association with intracellular Ca2+ mobilisation has yet to be determined.

Fifteen CFS/ME patients (mean age 48.82 ± 9.83 years) and 25 health controls (mean age 39.2 ± 12.12 years) were examined.

Isolated NK cells were labelled with fluorescent antibodies to determine TRPM3, CD107a, and CD69 receptors on CD56Dim CD16+ NK cells and CD56Bright CD16Dim/- NK cells. Ca2+ flux and NK cytotoxicity activity was measured under various stimulants including PregS, Thapsigargin, 2APB and ionomycin.

Unstimulated CD56Bright CD16Dim/- NK cells, significantly reduced TRPM3 receptors were seen in CFS/ME compared with HC. Ca2+ flux showed no significant difference between groups. Moreover PregS stimulated CD56Bright CD16Dim/- NK cells showed significant increase in Ca2+ flux in CFS/ME patients compared with HC.

By comparison, unstimulated CD56Dim CD16+ NK cell showed no significant difference in both Ca2+ flux and TRPM3 expression. PregS stimulated CD56Dim CD16+ NK cells significantly increased TRPM3 expression in CFS/ME but this was not associated with a significant increase in Ca2+ flux. Furthermore, TG stimulated CD56Dim CD16+ NK cells increased K562 cell lysis prior to PregS stimulation in CFS/ME patients compared with healthy controls.

Differential expression of TRPM3 and Ca2+ flux between NK cell sub-types may provide evidence for their role in the pathomechanism involving NK cell cytotoxicity activity in CFS/ME.

Calcium mobilisation in natural killer cells from Chronic fatigue syndrome/Myalgic encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels, by T Nguyen, S Johnston, L Clarke, P Smith, D Staines, S Marshall-Gradisnik in Clin Exp Immunol. 2016 Oct 11. [Epub ahead of print]

 

Posted in News | Tagged , , , , , , , , , | Comments Off on Calcium mobilisation in natural killer cells & cell cytotoxicity in CFS/ME